3rd Obesity & Weight Loss Drug Development Summit

The 3rd Obesity & Weight Loss Drug Development Summit is the place to be for experts in weight loss drug development tackling the obesity epidemic. This year, we're evaluating the obesity landscape, diving deep into the game-changing potential of novel targets and the latest GLP combination therapies to manage side effects and personalise patient treatment. Hear from the titans of the pharmaceutical industry – Eli Lilly, Novo Nordisk, Boehringer Ingelheim as well as innovative biotechs including, Altimmune, High Tide Therapeutics, and iBio, and many more – as they share their groundbreaking research and strategies for developing more effective, tolerable, and long-lasting weight management solutions. Obesity rates are increasing, and the pressure is on for real change. Don't miss this pivotal opportunity to network with 70+ obesity scientists and drug development experts forge collaborations, and be part of the solution. The future of weight loss treatment is being written now – be there!

Event Links

Website: https://go.evvnt.com/2904709-0

Tickets: https://go.evvnt.com/2904709-2

Brochure: https://go.evvnt.com/2904709-3

Read More

View Less